BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15941082)

  • 21. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation.
    Merat R; Amara A; Lebbe C; de The H; Morel P; Saib A
    Int J Cancer; 2002 Feb; 97(6):791-5. PubMed ID: 11857356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma.
    Carbone A; Gloghini A; Vaccher E; Cerri M; Gaidano G; Dalla-Favera R; Tirelli U
    J Mol Diagn; 2005 Feb; 7(1):17-27. PubMed ID: 15681470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases.
    Cesarman E
    Recent Results Cancer Res; 2002; 159():27-37. PubMed ID: 11785841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Linking KSHV to human cancer.
    Wong EL; Damania B
    Curr Oncol Rep; 2005 Sep; 7(5):349-56. PubMed ID: 16091195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis.
    Liang C; Lee JS; Jung JU
    Semin Cancer Biol; 2008 Dec; 18(6):423-36. PubMed ID: 18948197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KSHV Genome Replication and Maintenance in Latency.
    Ueda K
    Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation.
    Deng JH; Zhang YJ; Wang XP; Gao SJ
    J Virol; 2004 Oct; 78(20):11108-20. PubMed ID: 15452231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) in Kaposi's sarcoma, malignant lymphoma, and other diseases.
    Knowles DM; Cesarman E
    Ann Oncol; 1997; 8 Suppl 2():123-9. PubMed ID: 9209655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of Kaposi's sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1.
    Giffin L; Yan F; Ben Major M; Damania B
    J Virol; 2014 Aug; 88(16):9429-41. PubMed ID: 24920810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KSHV non-structural membrane proteins involved in the activation of intracellular signaling pathways and the pathogenesis of Kaposi's sarcoma.
    Abere B; Schulz TF
    Curr Opin Virol; 2016 Oct; 20():11-19. PubMed ID: 27518127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not.
    Quinlivan EB; Zhang C; Stewart PW; Komoltri C; Davis MG; Wehbie RS
    J Infect Dis; 2002 Jun; 185(12):1736-44. PubMed ID: 12085319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human herpesvirus 8: biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignancies.
    Viejo-Borbolla A; Ottinger M; Schulz TF
    Curr HIV/AIDS Rep; 2004 Apr; 1(1):5-11. PubMed ID: 16091217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma.
    Klass CM; Offermann MK
    Curr Opin Oncol; 2005 Sep; 17(5):447-55. PubMed ID: 16093794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kaposi's sarcoma herpesvirus-induced endothelial cell reprogramming supports viral persistence and contributes to Kaposi's sarcoma tumorigenesis.
    Gramolelli S; Ojala PM
    Curr Opin Virol; 2017 Oct; 26():156-162. PubMed ID: 29031103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS.
    Chang Y; Moore PS
    Infect Agents Dis; 1996 Oct; 5(4):215-22. PubMed ID: 8884366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma.
    Gruffat H; Sergeant A; Manet E
    Microbes Infect; 2000 May; 2(6):671-80. PubMed ID: 10884618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus.
    Boshoff C; Chang Y
    Annu Rev Med; 2001; 52():453-70. PubMed ID: 11160789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.